| Oct 15 |
Attovia Therapeutics Appoints Chief Financial Officer
|
| Sep 10 |
Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
|
| Sep 5 |
Connect Biopharma GAAP EPS of $0.14, revenue of $24.12M beats by $3.12M
|
| Sep 5 |
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
|
| Aug 29 |
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth Plans
|
| Jul 1 |
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
|
| Jun 12 |
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
| Jun 12 |
Connect Biopharma appoints Barry Quart as CEO
|
| Jun 12 |
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
|
| Jun 9 |
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders
|
